サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545519

電気刺激装置の世界市場

Electrical Stimulation Devices

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
電気刺激装置の世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

電気刺激装置の世界市場は2030年までに157億米ドルに到達

2023年に92億米ドルと推定される電気刺激装置の世界市場は、2023年から2030年にかけてCAGR 8.0％で成長し、2030年には157億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである疼痛管理アプリケーションは、CAGR 8.3%を記録し、分析期間終了時には54億米ドルに達すると予測されます。神経学・運動障害管理アプリケーション分野の成長率は、分析期間中CAGR 9.5%と推定されます。

米国市場は25億米ドルと推定、中国はCAGR 7.4％で成長予測

米国の電気刺激装置市場は2023年に25億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに24億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.3％と6.4％と予測されています。欧州では、ドイツがCAGR約6.5%で成長すると予測されています。

世界の電気刺激装置市場- 主要動向と促進要因のまとめ

電気刺激装置はどのようにリハビリや疼痛管理に革命を起こしているのか？

電気刺激装置は、リハビリテーション、疼痛管理、筋力再教育の分野に変革をもたらしつつあります。患部に電気パルスを送るこれらの機器は、神経や筋肉を刺激するために使用され、様々な医療現場で治療効果をもたらします。経皮的電気神経刺激（TENS）、機能的電気刺激（FES）、神経筋電気刺激（NMES）などの技術は、傷害や神経疾患のある患者の痛みを和らげ、筋萎縮を抑え、運動機能を改善するために広く利用されています。中枢神経系の自然な働きを模倣することで、これらの装置は、最適に機能していない筋肉を活性化し、血液循環を促進し、エンドルフィンを放出して痛みの感覚を軽減することができます。この非侵襲的なアプローチは、医薬品による鎮痛に代わるものを探している患者や、術後の回復期にある患者にとって特に価値があり、生活の質を著しく高め、回復への道を早める。

どのような技術革新が電気刺激装置の機能性を高めているのでしょうか？

電気刺激技術の革新は、これらの装置の有効性、使いやすさ、利用しやすさを高めることに重点を置いています。最近の進歩には、装置の遠隔操作を可能にするワイヤレス技術の統合が含まれ、ユーザーの利便性を高め、より柔軟な治療オプションを可能にしています。また、患者が日常生活で使用でき、日常生活を妨げることなく継続的な治療とモニタリングが可能なウェアラブル刺激装置の開発も大きく進展しています。さらに、電極設計の改善により、デバイスはより快適で、電気パルスを標的部位に効率的に届けることができるようになった。人工知能（AI）は、ユーザーの身体からのリアルタイムのフィードバックに基づいて刺激パターンを適応させ、個々のニーズに合わせた治療結果を最適化できるアルゴリズムで、大きな進歩を遂げているもう一つの分野です。このような技術的強化は、患者の転帰を改善するだけでなく、現代医療の重要な要素として電気刺激を広く採用し、受け入れることにも貢献しています。

電気刺激装置はヘルスケアの持続可能性にどのような影響を与えていますか？

電気刺激装置は、薬物療法や侵襲的処置への依存を減らす、費用対効果の高い非薬物療法の治療オプションを提供することで、ヘルスケアの持続可能性に大きく貢献します。これらのデバイスで疼痛を管理し、筋機能を促進することにより、ヘルスケアプロバイダーは、しばしば高価で、副作用や中毒の可能性のあるオピオイドや他の鎮痛剤の使用を最小限に抑えることができます。さらに、電気刺激は、患者が自宅で自分の状態を管理できるようにすることで、繰り返しの受診や長期入院の必要性を減らし、全体的な医療費と資源の使用を減らすことができます。このシフトは、ヘルスケアシステムの経済的負担を軽減するだけでなく、患者が自分の治療をよりコントロールできるようにし、全体的な健康転帰と患者満足度の向上につながります。

電気刺激装置市場の成長を促進する動向とは？

電気刺激装置市場は、世界の高齢化、慢性疼痛や神経疾患の有病率の上昇、非侵襲的治療に対する認識と受容の高まりなど、いくつかの主要動向によって力強い成長を遂げています。人口の高齢化に伴い、関節炎、筋力低下、神経変性疾患など、電気刺激によって改善できる加齢関連疾患に対する効果的な治療に対する需要が高まっています。さらに、慢性疼痛の世界の負担が増加するにつれて、薬に頼らない代替療法を求める患者や医療従事者が増え、電気刺激装置の需要に拍車をかけています。また、これらの機器をより使いやすく効果的なものにする技術の進歩も、導入の拡大に寄与しています。さらに、新興国におけるヘルスケア・インフラとサービスの拡大も、こうした革新的な治療法の普及にさらなる機会をもたらしています。これらの動向は総体的に、現代のヘルスケアにおける電気刺激の役割の拡大と、世界中の患者の生活を向上させる可能性を強調しています。

調査対象企業の例（全18件）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTL Industries, Inc.
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO Global, Inc.
  • Medtronic PLC
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • Zynex Medical

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11720

Global Electrical Stimulation Devices Market to Reach US$15.7 Billion by 2030

The global market for Electrical Stimulation Devices estimated at US$9.2 Billion in the year 2023, is expected to reach US$15.7 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Pain Management Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Neurological & Movement Disorder Management Application segment is estimated at 9.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.4% CAGR

The Electrical Stimulation Devices market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Electrical Stimulation Devices Market - Key Trends and Drivers Summarized

How Are Electrical Stimulation Devices Revolutionizing Rehabilitation and Pain Management?

Electrical stimulation devices are transforming the fields of rehabilitation, pain management, and muscular retraining. These devices, which deliver electrical pulses to affected areas, are used to stimulate nerves and muscles, providing therapeutic benefits in various medical settings. Techniques such as Transcutaneous Electrical Nerve Stimulation (TENS), Functional Electrical Stimulation (FES), and Neuromuscular Electrical Stimulation (NMES) are widely utilized to alleviate pain, reduce muscle atrophy, and improve motor function in patients with injuries or neurological conditions. By mimicking the natural action of the central nervous system, these devices can activate muscles that are not functioning optimally, enhance blood circulation, and release endorphins to reduce pain sensations. This non-invasive approach is particularly valuable for patients seeking alternatives to pharmaceutical pain relief or those in postoperative recovery, significantly enhancing quality of life and accelerating the path to recovery.

What Innovations Are Enhancing the Functionality of Electrical Stimulation Devices?

Innovation in electrical stimulation technology is focused on enhancing the effectiveness, user-friendliness, and accessibility of these devices. Modern advancements include the integration of wireless technologies, which allow for remote control of the devices, increasing convenience for users and enabling more flexible treatment options. There is also significant progress in developing wearable stimulation devices that patients can use in their everyday lives, providing continuous therapy and monitoring without disrupting daily activities. Moreover, improvements in electrode design have made devices more comfortable and efficient at delivering electrical pulses to the target areas. Artificial intelligence (AI) is another area where substantial strides are being made, with algorithms that can adapt stimulation patterns based on real-time feedback from the user's body, optimizing therapeutic outcomes tailored to individual needs. These technological enhancements not only improve patient outcomes but also contribute to broader adoption and acceptance of electrical stimulation as a critical component of modern medical care.

How Do Electrical Stimulation Devices Impact Healthcare Sustainability?

Electrical stimulation devices contribute significantly to healthcare sustainability by offering cost-effective, non-pharmacological treatment options that reduce dependence on medication and invasive procedures. By managing pain and facilitating muscle function with these devices, healthcare providers can minimize the use of opioids and other pain-relief drugs, which are often expensive and have the potential for side effects and addiction. Additionally, electrical stimulation can reduce the need for repeated medical visits or prolonged hospital stays by enabling patients to manage their conditions at home, thereby decreasing overall healthcare costs and resource use. This shift not only alleviates the financial burden on healthcare systems but also empowers patients with more control over their treatment, leading to better overall health outcomes and patient satisfaction.

What Trends Are Driving Growth in the Electrical Stimulation Devices Market?

The market for electrical stimulation devices is experiencing robust growth driven by several key trends, including the aging global population, the rising prevalence of chronic pain and neurological disorders, and increased awareness and acceptance of non-invasive therapies. As the population ages, there is a higher demand for effective treatments for age-related conditions such as arthritis, muscle weakness, and neurodegenerative diseases, which can be ameliorated through electrical stimulation. Furthermore, as the global burden of chronic pain increases, more patients and healthcare providers are looking for alternative therapies that do not rely on medications, thereby fueling demand for electrical stimulation devices. Advances in technology that make these devices more user-friendly and effective also contribute to their growing adoption. Additionally, the expansion of healthcare infrastructure and services in emerging economies provides further opportunities for the penetration of these innovative therapies. These trends collectively underscore the expanding role of electrical stimulation in contemporary healthcare and its potential to enhance the lives of patients worldwide.

Select Competitors (Total 18 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTL Industries, Inc.
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO Global, Inc.
  • Medtronic PLC
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • Zynex Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Electrical Stimulation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Neurological Disorders Globally Drives Demand for Electrical Stimulation Devices
    • Technological Breakthroughs in Neuromodulation Propel Market Growth
    • Aging Populations Worldwide Expand Addressable Market for Pain Management Therapies
    • Innovations in Wearable Electrical Stimulation Devices Strengthen Business Cases
    • Expanding Insurance Coverage for Rehabilitation Devices Accelerates Market Adoption
    • Market Trends Toward Home-based Therapy and the Rise of Telehealth
    • Increasing Clinical Evidence Supporting the Efficacy of Electrical Stimulation
    • Expanding Application in Veterinary Medicine Opens New Market Avenues
    • Market Dynamics Driven by Increasing Healthcare Expenditure
    • Research Focus on Deep Brain Stimulation and Its Expanding Indications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation (SCS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Spinal Cord Stimulation (SCS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Spinal Cord Stimulation (SCS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Brain Stimulation (DBS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Deep Brain Stimulation (DBS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Deep Brain Stimulation (DBS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Vagus Nerve Stimulation (VNS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Sacral Nerve Stimulation (SNS) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Neurological & Movement Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Neurological & Movement Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Neurological & Movement Disorder Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Musculoskeletal Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Musculoskeletal Disorder Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Musculoskeletal Disorder Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Metabolism & GIT Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Metabolism & GIT Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Metabolism & GIT Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Electrical Stimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Electrical Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Electrical Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Electrical Stimulation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Electrical Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Electrical Stimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Electrical Stimulation Devices by Device - Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Electrical Stimulation Devices by Device - Percentage Breakdown of Value Sales for Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices and Other Devices for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Electrical Stimulation Devices by Application - Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Electrical Stimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Neurological & Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION